Free Trial

Bioventus (BVS) SEC Filings & 10K Form

Bioventus logo
$11.30 +0.15 (+1.35%)
(As of 08:22 AM ET)

Recent Bioventus SEC Filings

DateFilerForm TypeView
11/14/2024
3:53 PM
Bioventus (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
11/08/2024
8:13 PM
Bioventus (Subject)
Spindletop Healthcare Capital, L.P. (Filed by)
Form SC 13G/A
11/05/2024
6:34 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:36 AM
Bioventus (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
11:15 PM
Bioventus (Filer)
Form EFFECT
10/25/2024
3:14 PM
Bioventus (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/04/2024
6:45 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:16 PM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
6:40 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:51 AM
Bioventus (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
3:16 PM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
4:15 PM
AMP-CF Holdings, LLC (Filed by)
Bioventus (Subject)
Form SC 13G/A
06/24/2024
7:45 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:45 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:46 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:30 PM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:24 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:25 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:27 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:44 PM
Bioventus (Issuer)
McMurry-Heath Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:40 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:40 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:42 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:43 PM
Beyer Pat (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:43 PM
Bioventus (Issuer)
Ladone Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:53 PM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
4:28 PM
Bioventus (Issuer)
SUTTER MARTIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:24 PM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:25 PM
Beyer Pat (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:25 PM
Bioventus (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:26 PM
Bioventus (Issuer)
Ladone Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:26 PM
Bioventus (Issuer)
McMurry-Heath Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:27 PM
Bioventus (Issuer)
NEELS GUIDO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:27 PM
Bioventus (Issuer)
NOHRA GUY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:28 PM
Bioventus (Issuer)
STALNECKER SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:43 PM
Beyer Pat (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:44 PM
Bioventus (Issuer)
McMurry-Heath Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:44 PM
Bioventus (Issuer)
Ladone Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:45 PM
Bioventus (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:45 PM
Bioventus (Issuer)
NEELS GUIDO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:46 PM
Bioventus (Issuer)
NOHRA GUY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
06/11/2024
7:46 PM
Bioventus (Issuer)
STALNECKER SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:47 PM
Bioventus (Issuer)
SUTTER MARTIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:43 PM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:40 PM
Bartholdson John A. (Reporting)
Bioventus (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:33 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:36 AM
Bioventus (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
6:43 AM
Bioventus (Filer)
Form ARS
04/26/2024
6:38 AM
Bioventus (Filer)
Form DEF 14A
04/26/2024
6:40 AM
Bioventus (Filer)
Form DEFA14A
04/15/2024
4:58 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
5:00 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
5:03 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:53 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:53 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:54 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
8:29 AM
Bioventus (Subject)
Singleton Mark Leonard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2024
8:33 AM
Bioventus (Subject)
CHURCH KATRINA J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2024
8:18 AM
Bioventus (Subject)
D'Adamio Anthony (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:08 PM
Bioventus (Filer)
Form PRE 14A
03/27/2024
4:46 PM
Bihl Anthony P III (Reporting)
Bioventus (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
4:36 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:53 PM
Bihl Anthony P III (Reporting)
Bioventus (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
4:21 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:21 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:22 PM
Bioventus (Issuer)
Singleton Mark Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:41 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:41 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:45 PM
Bioventus (Issuer)
CHURCH KATRINA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:47 PM
Bioventus (Issuer)
D'Adamio Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:51 AM
Bioventus (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2024
6:45 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
3:07 PM
Bioventus (Subject)
EW HEALTHCARE PARTNERS ACQUISITION FUND, L.P. (Filed by)
Form SC 13G/A
01/19/2024
7:27 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
4:10 PM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:52 PM
Bioventus (Issuer)
Claypoole Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:39 PM
Bioventus (Issuer)
Claypoole Robert E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2024
7:55 AM
Bioventus (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/21/2023
7:00 AM
Bioventus (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:BVS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners